Delivery Order SPE2DB24D1201-SPE2DB25FJDVC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- The Defense Logistics Agency awarded a delivery order valued at $1,327.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count unit dosage) with a firm fixed price structure. The award, issued on July 31, 2025, is set to be completed by August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,898.04 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract, executed without set-aside provisions, represents a competitively awarded procurement under the agency's pharmaceutical supply chain. The award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the...
- This delivery order, valued at $4,138.47, awards AmerisourceBergen Drug Corp the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, issued by the Defense Logistics Agency under the Department of Defense, is a non-set-aside, competitively awarded delivery order with firm fixed pricing. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $24,376.15 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,987.45 for DESCOVY 200-25 mg tablets (30 units), with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) with a ceiling value of $9,814.86. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 MG tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $21,761.46 and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $13,203.86 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a continuation of the company's role as a critical supplier within the federal medical supply chain, specifically...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDVCDelivery Order
The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger pharmaceutical support vehicle, this delivery order represents one of numerous competitively awarded transactions through which the company fulfills federal medical supply requirements for the Defense Health Agency and other military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds an Indefinite Delivery Contract valued at $999,999,999.00 with DLA Troop Support Medical through December 2026, which serves as the framework for this and similar delivery orders. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. This DESCOVY order reflects AmerisourceBergen's established role as a critical vendor for federal pharmaceutical procurement, with the Defense Logistics Agency responsible for managing the supply chain for Department of Defense medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 8/7/25 |